Next Article in Journal
Essential Oils and Their Main Chemical Components: The Past 20 Years of Preclinical Studies in Melanoma
Previous Article in Journal
Tissue Immune Profile: A Tool to Predict Response to Neoadjuvant Therapy in Triple Negative Breast Cancer
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Erratum

Erratum: Lee, H.H., et al. Histone 2A Family Member J Drives Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Multiforme. Cancers 2020, 12, 98

1
Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan
2
Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan
3
Dizziness and Balance Disorder Center, Shuang-Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan
4
Department of Neurology, Shuang-Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan
5
Taipei Neuroscience Institute, Taipei Medical University, New Taipei City 23561, Taiwan
6
Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan
7
Department of Otolaryngology, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan
8
Department of Otolaryngology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan
9
Breast Center, Department of General Surgery, Cardinal Tien Hospital, Xindian District, New Taipei City 231, Taiwan
10
Urology, Division of Surgery, Cardinal Tien Hospital, Xindian District, New Taipei City 231, Taiwan
11
Department of Critical Care Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan
12
Department of Medical Research, Shuang-Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan
13
Department of Radiation Oncology, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan
14
Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei 11031, Taiwan
15
Department of Otolaryngology, Shuang-Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan
16
Sleep Center, Shuang-Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan
17
Cell Physiology and Molecular Image Research Center, Wan Fang Hospital, Taipei Medical University, Taipei 116, Taiwan
*
Authors to whom correspondence should be addressed.
Cancers 2020, 12(9), 2649; https://doi.org/10.3390/cancers12092649
Submission received: 2 July 2020 / Accepted: 24 August 2020 / Published: 16 September 2020
The authors wish to make the following changes to this paper [1].
The affiliation numbers of the authors Che-Hsuan Lin, Long-Sheng Lu, and Dean Wu are not correct in the original published version.
The original version is
  • Hsun-Hua Lee 1,2,3,4,5, Che-Hsuan Lin 6,7, Hui-Yu Lin 1,8, Chia-Hao Kuei 1,9, Jing-Quan Zheng 1,10, Yuan-Hung Wang 1,11, Long-Sheng Lu 12, Fei-Peng Lee 13,14, Chaur-Jong Hu 1,2, Dean Wu 1,3,4,5,15,* and Yuan-Feng Lin 1,16,*
1 
Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan; [email protected] (H.-H.L.); [email protected] (H.-Y.L.); [email protected] (C.-H.K.); [email protected] (J.-Q.Z.); [email protected] (Y.-H.W.); [email protected] (C.-J.H.)
2 
Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan
3 
Dizziness and Balance Disorder Center, Shuang-Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan
4 
Department of Neurology, Shuang-Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan
5 
Taipei Neuroscience Institute, Taipei Medical University, New Taipei City 23561, Taiwan
6 
Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan; [email protected]
7 
Department of Otolaryngology, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan
8 
Breast Center, Department of General Surgery, Cardinal Tien Hospital, Xindian District, New Taipei City 231, Taiwan
9 
Urology, Division of Surgery, Cardinal Tien Hospital, Xindian District, New Taipei City 231, Taiwan
10 
Department of Critical Care Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan
11 
Department of Medical Research, Shuang-Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan
12 
Department of Radiation Oncology, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan; [email protected]
13 
Department of Otolaryngology, Shuang-Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan; [email protected]
14 
Department of Otolaryngology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan
15 
Sleep Center, Shuang-Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan
16 
Cell Physiology and Molecular Image Research Center, Wan Fang Hospital, Taipei Medical University, Taipei 116, Taiwan
And should be replaced with
  • Hsun-Hua Lee 1,2,3,4,5, Che-Hsuan Lin 6,7,8, Hui-Yu Lin 1,9, Chia-Hao Kuei 1,10, Jing-Quan Zheng 1,11, Yuan-Hung Wang 1,12, Long-Sheng Lu 13,14, Fei-Peng Lee 8,15, Chaur-Jong Hu 1,2, Dean Wu 1,2,4,5,16,* and Yuan-Feng Lin 1,17,*
1 
Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan; [email protected] (H.-H.L.); [email protected] (H.-Y.L.); [email protected] (C.-H.K.); [email protected] (J.-Q.Z.); [email protected] (Y.-H.W.); [email protected] (C.-J.H.)
2 
Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan
3 
Dizziness and Balance Disorder Center, Shuang-Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan
4 
Department of Neurology, Shuang-Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan
5 
Taipei Neuroscience Institute, Taipei Medical University, New Taipei City 23561, Taiwan
6 
Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan; [email protected]
7 
Department of Otolaryngology, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan
8 
Department of Otolaryngology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan; [email protected]
9 
Breast Center, Department of General Surgery, Cardinal Tien Hospital, Xindian District, New Taipei City 231, Taiwan
10 
Urology, Division of Surgery, Cardinal Tien Hospital, Xindian District, New Taipei City 231, Taiwan
11 
Department of Critical Care Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan
12 
Department of Medical Research, Shuang-Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan
13 
Department of Radiation Oncology, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan; [email protected]
14 
Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei 11031, Taiwan
15 
Department of Otolaryngology, Shuang-Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan
16 
Sleep Center, Shuang-Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan
17 
Cell Physiology and Molecular Image Research Center, Wan Fang Hospital, Taipei Medical University, Taipei 116, Taiwan
The order of affiliations has been adjusted to make sure they appear in numerical order.
The authors apologize for any inconvenience brought to the readers by these changes. These changes do not affect the scientific results. The manuscript will be updated, and the original will remain online on the article webpage.

Reference

  1. Lee, H.-H.; Lin, C.-H.; Lin, H.-Y.; Kuei, C.-H.; Zheng, J.-Q.; Wang, Y.-H.; Lu, L.-S.; Lee, F.-P.; Hu, C.-J.; Wu, D.; et al. Histone 2A Family Member J Drives Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Multiforme. Cancers 2020, 12, 98. [Google Scholar] [CrossRef] [Green Version]

Share and Cite

MDPI and ACS Style

Lee, H.-H.; Lin, C.-H.; Lin, H.-Y.; Kuei, C.-H.; Zheng, J.-Q.; Wang, Y.-H.; Lu, L.-S.; Lee, F.-P.; Hu, C.-J.; Wu, D.; et al. Erratum: Lee, H.H., et al. Histone 2A Family Member J Drives Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Multiforme. Cancers 2020, 12, 98. Cancers 2020, 12, 2649. https://doi.org/10.3390/cancers12092649

AMA Style

Lee H-H, Lin C-H, Lin H-Y, Kuei C-H, Zheng J-Q, Wang Y-H, Lu L-S, Lee F-P, Hu C-J, Wu D, et al. Erratum: Lee, H.H., et al. Histone 2A Family Member J Drives Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Multiforme. Cancers 2020, 12, 98. Cancers. 2020; 12(9):2649. https://doi.org/10.3390/cancers12092649

Chicago/Turabian Style

Lee, Hsun-Hua, Che-Hsuan Lin, Hui-Yu Lin, Chia-Hao Kuei, Jing-Quan Zheng, Yuan-Hung Wang, Long-Sheng Lu, Fei-Peng Lee, Chaur-Jong Hu, Dean Wu, and et al. 2020. "Erratum: Lee, H.H., et al. Histone 2A Family Member J Drives Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Multiforme. Cancers 2020, 12, 98" Cancers 12, no. 9: 2649. https://doi.org/10.3390/cancers12092649

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop